Previous close | 93.13 |
Open | 93.20 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 1400 |
Day's range | 93.05 - 95.72 |
52-week range | 70.89 - 95.72 |
Volume | |
Avg. volume | 12,323,077 |
Market cap | 238.745B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 17.23 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.76 (2.92%) |
Ex-dividend date | 14 Jun 2022 |
1y target est | N/A |
RAHWAY, N.J., June 27, 2022--LYNPARZA® Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
RAHWAY, N.J., June 24, 2022--European Commission Approves KEYTRUDA as Adjuvant Treatment for Adult & Adolescent Patients With Stage IIB or IIC Melanoma After Complete Resection
RAHWAY, N.J., June 22, 2022--CDC’s ACIP Unanimously Votes to Provisionally Recommend Use of Merck’s VAXNEUVANCE™ as an Option for Pneumococcal Vaccination in Infants and Children